Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring.


Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 29 04 2019
revised: 15 08 2019
accepted: 28 08 2019
pubmed: 10 9 2019
medline: 21 8 2020
entrez: 10 9 2019
Statut: ppublish

Résumé

In retrospective studies, a second primary melanoma (SPM) develops in 2%-20% of melanoma patients. Scarce evidence exists on the usefulness of total-body photography (TBP) and digital dermatoscopic documentation (DDD) for detecting SPMs. The primary aim was to quantify the risk and investigate the time of occurrence of SPMs. Secondary aims were to identify risk factors for SPM and to assess the usefulness of TBP and DDD for SPM detection. This prospective cohort included patients with recently diagnosed melanoma that underwent sequential clinical and dermatoscopic examinations for up to 5 years. Life table analysis and Kaplan-Meier survival analysis were performed. Multivariate Cox models were constructed to identify factors affecting the outcome. An SPM developed in 46 of 977 (4.7%) patients. Life table analysis revealed a 5-year cumulative risk of 8.0% for SPM. High nevus count, fair phototype, and occupational sun exposure were potent predictors of SPM. Of all new melanomas, 17.3% were diagnosed by clinical and dermatoscopic examination, 48.1% by TBP, and 34.6% by DDD. All patients followed the same protocol and diagnostic bias associated with sequential dermatoscopic imaging. In this cohort, melanoma patients were at 8% risk of an SPM developing within 5 years. TBP and DDD significantly contributed to the early detection of SPM.

Sections du résumé

BACKGROUND BACKGROUND
In retrospective studies, a second primary melanoma (SPM) develops in 2%-20% of melanoma patients. Scarce evidence exists on the usefulness of total-body photography (TBP) and digital dermatoscopic documentation (DDD) for detecting SPMs.
OBJECTIVE OBJECTIVE
The primary aim was to quantify the risk and investigate the time of occurrence of SPMs. Secondary aims were to identify risk factors for SPM and to assess the usefulness of TBP and DDD for SPM detection.
METHODS METHODS
This prospective cohort included patients with recently diagnosed melanoma that underwent sequential clinical and dermatoscopic examinations for up to 5 years. Life table analysis and Kaplan-Meier survival analysis were performed. Multivariate Cox models were constructed to identify factors affecting the outcome.
RESULTS RESULTS
An SPM developed in 46 of 977 (4.7%) patients. Life table analysis revealed a 5-year cumulative risk of 8.0% for SPM. High nevus count, fair phototype, and occupational sun exposure were potent predictors of SPM. Of all new melanomas, 17.3% were diagnosed by clinical and dermatoscopic examination, 48.1% by TBP, and 34.6% by DDD.
LIMITATIONS CONCLUSIONS
All patients followed the same protocol and diagnostic bias associated with sequential dermatoscopic imaging.
CONCLUSION CONCLUSIONS
In this cohort, melanoma patients were at 8% risk of an SPM developing within 5 years. TBP and DDD significantly contributed to the early detection of SPM.

Identifiants

pubmed: 31499156
pii: S0190-9622(19)32682-9
doi: 10.1016/j.jaad.2019.08.074
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

398-406

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Aimilios Lallas (A)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece. Electronic address: emlallas@gmail.com.

Zoe Apalla (Z)

State Clinic of Dermatology, Hospital for Skin and Venereal Diseases, Thessaloniki, Greece.

Athanassios Kyrgidis (A)

Department of Clinical Pharmacology, Aristotle University, Thessaloniki, Greece.

Chryssoula Papageorgiou (C)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Ioannis Boukovinas (I)

Oncology Unit, Bioclinic of Thessaloniki, Thessaloniki, Greece.

Mattheos Bobos (M)

Microdiagnostics Pathology Laboratory, Thessaloniki, Greece.

George Efthimiopoulos (G)

Department of Surgical Oncology, Theageneio Anticancer Hospital, Thessaloniki, Greece.

Christina Nikolaidou (C)

Department of Histopathology, Hippokration General Hospital, Thessaloniki, Greece.

Andreas Moutsoudis (A)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Theodosia Gkentsidi (T)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Konstantinos Lallas (K)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Elizabeth Lazaridou (E)

Second Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Elena Sotiriou (E)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Efstratios Vakirlis (E)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Dimitrios Ioannides (D)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH